Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Safety and efficacy of sparsentan versus irbesartan in focal segmental glomerulosclerosis and IgA nephropathy: a systematic review and meta-analysis of randomized controlled trials

PaperCitations, authors & open-access status

Safety and efficacy of sparsentan versus irbesartan in focal segmental glomerulosclerosis and IgA nephropathy: a systematic review and meta-analysis of randomized controlled trials is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 3 citations, 2024 year and gold oa status.

3
Citations
2024
Year
gold
OA Status

Related on ScholarIQ

Mohamed A. Alsaied
Author
Abdelrahman M. Elettreby
Author
BMC Nephrology
Journal
Renal Diseases and Glomerulopathies
Topic
Renal Diseases and Glomerulopathies
Topic
Chronic Kidney Disease and Diabetes
Topic
470M+ articles · free account